Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.5B 5.09B 4.68B 8.86B 600B 9.03B 60.67B 23.8B 295B 23.53B 23.02B 1,017B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.34B 4.95B 4.55B 8.61B 583B 8.78B 58.97B 23.13B 286B 22.87B 22.37B 989B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 month | +1.96% | ||
| 3 months | +2.35% | ||
| 6 months | +82.27% | ||
| Current year | +61.94% |
| 1 month | 39.66 |  | 40.56 |
| Current year | 21.5 | | 40.56 |
| 1 year | 14.75 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-23 | Issuer sale | Controller/Auditor | -218,000 | 0.1409% | ||
| 06-23 | Issuer sale | Chief Technology Officer | -620,000 | 0.4007% | ||
| 06-23 | Issuer sale | Director | -392,474 | 0.2537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +180.67% | +441.44% | 6.27B | |
| -0.90% | +1.92% | +3.68% | +7.53% | 50.61B | |
| +1.27% | -2.79% | +382.53% | +594.47% | 39.11B | |
| -1.07% | -0.70% | +29.13% | -6.48% | 34.64B | |
| +0.21% | -2.00% | +20.08% | +54.22% | 33.79B | |
| -0.06% | -0.45% | +2.94% | +28.70% | 26.89B | |
| +0.41% | -0.94% | - | - | 16.47B | |
| +0.02% | -2.86% | +65.64% | +118.19% | 15.14B | |
| -0.23% | +0.61% | +15.26% | +17.53% | 13.85B | |
| +0.15% | -2.02% | +10.56% | -32.87% | 12.72B | |
| Average | +0.09% | -1.15% | +78.94% | +135.86% | 24.95B | |
| Weighted average by Cap. | -0.02% | -1.01% | +83.19% | +130.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.16 12.19 11.21 21.21 1.44K 21.62 145.23 56.96 705.03 56.33 55.1 2.43K |
| Net income | -236M -207M -192M -176M -333M -22.56B -340M -2.28B -895M -11.08B -885M -866M -38.27B | -198M -173M -160M -148M -279M -18.91B -285M -1.91B -750M -9.28B -742M -726M -32.06B |
| Net Debt | -364M -320M -296M -272M -515M -34.87B -525M -3.53B -1.38B -17.13B -1.37B -1.34B -59.14B | -176M -155M -143M -132M -249M -16.86B -254M -1.71B -669M -8.28B -662M -647M -28.6B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
